WALVAX(SZ:300142) Sou Hu Cai Jing·2025-11-04 02:24Core Insights - Watson Bio (300142) reported a financing net purchase of 2.9982 million yuan on November 3, 2025, with a financing balance of 1.885 billion yuan, indicating a positive investor sentiment in recent trading days [1][4]. Financing Activity - On November 3, 2025, the financing net purchase was 2.9982 million yuan, with a financing balance of 1.885 billion yuan, representing 9.99% of the circulating market value [2]. - Over the past three trading days, the cumulative net purchase reached 29.8997 million yuan [1]. - The financing balance has shown a slight increase from 1.882 billion yuan on October 31 to 1.885 billion yuan on November 3, reflecting a 0.17% increase [4]. Margin Trading Activity - On November 3, 2025, there was a margin sellout of 22,900 shares, with a net sellout of 22,900 shares, resulting in a margin balance of 1.07309 million yuan [3]. - The margin trading activity has shown a trend of net sellouts over the past three trading days, totaling 67,600 shares [3]. - The margin balance has fluctuated, with a notable decrease in recent days, indicating a potential shift in market sentiment [3].